Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jan A Burger

Showing results (51-60 of 223) with videos related to

Pageof 23
Sort By:
Leukemia & Lymphoma|May 11, 2002
Chemokine receptors and stromal cells in the homing and homeostasis of chronic lymphocytic leukemia B cellsJan A Burger, Thomas J Kipps
Biochimica Et Biophysica Acta|July 21, 2015
Microenvironment interactions and B-cell receptor signaling in Chronic Lymphocytic Leukemia: Implications for disease pathogenesis and treatmentElisa Ten Hacken, Jan A Burger
Pharmacology & Therapeutics|July 23, 2014
Microenvironment dependency in Chronic Lymphocytic Leukemia: The basis for new targeted therapiesElisa ten Hacken, Jan A Burger
Frontiers in Immunology|June 28, 2021
Resistance Mutations to BTK Inhibitors Originate From the NF-κB but Not From the PI3K-RAS-MAPK Arm of the B Cell Receptor Signaling PathwayC I Edvard Smith, Jan A Burger
Leukemia & Lymphoma|March 29, 2011
The microenvironment in hairy cell leukemia: pathways and potential therapeutic targetsJan A Burger, Mariela Sivina, Farhad Ravandi
American Journal of Hematology|July 4, 2017
CLL progression after one cycle of FCR: Richter's transformation versus EBV-associated lympho-proliferationPreetesh Jain, Jan A Burger, Joseph D Khoury
Proceedings of the National Academy of Sciences of the United States of America|September 10, 2014
Evolution of ibrutinib resistance in chronic lymphocytic leukemia (CLL)Natalia L Komarova, Jan A Burger, Dominik Wodarz
The New England Journal of Medicine|April 21, 2016
Ibrutinib for Chronic Lymphocytic LeukemiaJan A Burger, Lori Styles, Thomas J Kipps
Oncogene|February 3, 2005
KSHV-GPCR and CXCR2 transforming capacity and angiogenic responses are mediated through a JAK2-STAT3-dependent pathwayMeike Burger, Tanja Hartmann, Jan A Burger, et al.
International Journal of Molecular Sciences|November 27, 2024
Estimating the Number of Polygenic Diseases Among Six Mutually Exclusive Entities of Non-Tumors and CancerC I Edvard Smith, Jan A Burger, Rula Zain
Pageof 23

Showing results (51-60 of 223) with videos related to

Sort By:
Pageof 23
Leukemia & Lymphoma|May 11, 2002
Chemokine receptors and stromal cells in the homing and homeostasis of chronic lymphocytic leukemia B cellsJan A Burger, Thomas J Kipps
Biochimica Et Biophysica Acta|July 21, 2015
Microenvironment interactions and B-cell receptor signaling in Chronic Lymphocytic Leukemia: Implications for disease pathogenesis and treatmentElisa Ten Hacken, Jan A Burger
Pharmacology & Therapeutics|July 23, 2014
Microenvironment dependency in Chronic Lymphocytic Leukemia: The basis for new targeted therapiesElisa ten Hacken, Jan A Burger
Frontiers in Immunology|June 28, 2021
Resistance Mutations to BTK Inhibitors Originate From the NF-κB but Not From the PI3K-RAS-MAPK Arm of the B Cell Receptor Signaling PathwayC I Edvard Smith, Jan A Burger
Leukemia & Lymphoma|March 29, 2011
The microenvironment in hairy cell leukemia: pathways and potential therapeutic targetsJan A Burger, Mariela Sivina, Farhad Ravandi
American Journal of Hematology|July 4, 2017
CLL progression after one cycle of FCR: Richter's transformation versus EBV-associated lympho-proliferationPreetesh Jain, Jan A Burger, Joseph D Khoury
Proceedings of the National Academy of Sciences of the United States of America|September 10, 2014
Evolution of ibrutinib resistance in chronic lymphocytic leukemia (CLL)Natalia L Komarova, Jan A Burger, Dominik Wodarz
The New England Journal of Medicine|April 21, 2016
Ibrutinib for Chronic Lymphocytic LeukemiaJan A Burger, Lori Styles, Thomas J Kipps
Oncogene|February 3, 2005
KSHV-GPCR and CXCR2 transforming capacity and angiogenic responses are mediated through a JAK2-STAT3-dependent pathwayMeike Burger, Tanja Hartmann, Jan A Burger, et al.
International Journal of Molecular Sciences|November 27, 2024
Estimating the Number of Polygenic Diseases Among Six Mutually Exclusive Entities of Non-Tumors and CancerC I Edvard Smith, Jan A Burger, Rula Zain
Pageof 23